发明授权
US08101601B2 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
有权
用于治疗血栓栓塞性疾病的氨基酰基前药衍生物和药物
- 专利标题： Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
- 专利标题（中）： 用于治疗血栓栓塞性疾病的氨基酰基前药衍生物和药物
-
申请号： US12224007申请日： 2007-02-06
-
公开(公告)号： US08101601B2公开(公告)日： 2012-01-24
- 发明人: Hans-Georg Lerchen , Ursula Krenz , Karl-Heinz Schlemmer , Elisabeth Perzborn , Joerg Keldenich
- 申请人： Hans-Georg Lerchen , Ursula Krenz , Karl-Heinz Schlemmer , Elisabeth Perzborn , Joerg Keldenich
- 申请人地址： DE Berlin
- 专利权人： Bayer Pharma Aktiengesellschaft
- 当前专利权人： Bayer Pharma Aktiengesellschaft
- 当前专利权人地址： DE Berlin
- 国际申请： PCT/EP2007/001135 WO 20070206
- 国际公布： WO2007/093328 WO 20070823
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; C07D413/14 ; A61P7/02
摘要：
The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-morpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.
公开/授权文献
信息查询
IPC分类:
